Efficacy and Safety of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes

NCT00390520 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Vildagliptin

Sponsor

Novartis